EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus

Dereje A Negatu iD, Wassihun Wedajo Aragaw, Véronique Dartois iD, Thomas Dick iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02199-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Dereje A Negatu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The protein synthesis inhibitor linezolid is used for the treatment of lung disease caused by Mycobacterium abscessus . However, many strains of the bacterium show poor susceptibility to the antibiotic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusMycobacterium Infections, NontuberculousHumansLinezolidDrug Resistance, BacterialAnti-Bacterial AgentsProtein Synthesis InhibitorsMicrobial Sensitivity TestsMutation

Stichwörter der Autor:innen

MAB_4384MmpL5-MmpS5NTMTetRcross resistancenontuberculous mycobacteriaoxazolidinonesrplCrrl

Substanzen

LinezolidAnti-Bacterial AgentsProtein Synthesis Inhibitors

Autor:innen und Institutionen

  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Center for Innovative Drug Development and Therapeutic Trials for Africa, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.
  • Department of Microbiology and Immunology, Georgetown University, Washington, D.C., USA.

ORCID-Profile: Dereje A Negatu, Véronique Dartois, Thomas Dick

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Negatu, D. A., Aragaw, W. W., Dartois, V., & Dick, T. (2023). Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02199-23

Vancouver

Negatu DA, Aragaw WW, Dartois V, Dick T. Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02199-23

BibTeX
@article{Negatu2023,
  author = {Negatu, Dereje A and Aragaw, Wassihun Wedajo and Dartois, Véronique and Dick, Thomas},
  title = {Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02199-23}
}
Kostenlos starten →